PDE7A and Hepatitis: Furthermore, in the present study, the strong selective PDE7 inhibitor BRL-50481 reduced the concentrations of both IFN-γ and TNF-α and the activities of transaminases in the ConA-induced hepatitis model; however, the compound did not significantly influence the concentrations of IL-6 at the tested dose.